FinTrust Capital Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-44
Closed -$2.4K 1306
2023
Q3
$2.4K Buy
+44
New +$2.61K ﹤0.01% 991
2022
Q4
Sell
-1,225
Closed -$60K 1242
2022
Q3
$60K Sell
1,225
-360
-23% -$18K 0.02% 476
2022
Q2
$76K Buy
+1,585
New +$70.9K 0.02% 452

Other funds holding LMAT

FinTrust Capital Advisors's LMAT Position: Q4 2023 in Review

FinTrust Capital Advisors sold out of LeMaitre Vascular (LMAT) in Q4 2023, closing a stake of 44 shares — an estimated $2.4K sold.

FinTrust Capital Advisors first reported a position in LMAT in Q2 2022 and held it in 3 quarters. The position peaked at $76K in Q2 2022. 227 funds tracked by Wall St. Rank hold LMAT as of Q4 2023.

  • FinTrust Capital Advisors reported no remaining LeMaitre Vascular position as of Q4 2023 after selling out during the quarter.
  • FinTrust Capital Advisors sold 44 LeMaitre Vascular shares in Q4 2023, an estimated $2.4K.
  • FinTrust Capital Advisors first reported a position in LeMaitre Vascular in Q2 2022 and held it in 3 quarters.
  • FinTrust Capital Advisors's LeMaitre Vascular position peaked at $76K in Q2 2022.
  • 227 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2023.

Based on FinTrust Capital Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.